Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Assets (2021 - 2025)

Historic Return on Assets for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to 0.1%.

  • Journey Medical's Return on Assets rose 1800.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.19% for FY2024, which is 1400.0% down from last year.
  • Journey Medical's Return on Assets amounted to 0.1% in Q3 2025, which was up 1800.0% from 0.1% recorded in Q2 2025.
  • Journey Medical's 5-year Return on Assets high stood at 0.01% for Q2 2024, and its period low was 0.47% during Q2 2023.
  • For the 5-year period, Journey Medical's Return on Assets averaged around 0.24%, with its median value being 0.24% (2024).
  • Data for Journey Medical's Return on Assets shows a peak YoY increase of 4900bps (in 2024) and a maximum YoY decrease of -1500bps (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Journey Medical's Return on Assets stood at 0.47% in 2021, then surged by 41bps to 0.28% in 2022, then skyrocketed by 81bps to 0.05% in 2023, then tumbled by -275bps to 0.2% in 2024, then surged by 49bps to 0.1% in 2025.
  • Its Return on Assets was 0.1% in Q3 2025, compared to 0.1% in Q2 2025 and 0.1% in Q1 2025.